Skip to main content
Premium Trial:

Request an Annual Quote

Pressure Bio FY 2015 Revenues Up 31 Percent

NEW YORK (GenomeWeb) – Pressure Biosciences today reported a 31 percent increase in full-year 2015 revenues.

For the 12 months ended Dec. 31, the life sciences sample preparation technologies company recorded $1.8 million in total revenues, up from $1.4 million a year ago.

Products and services revenue was nearly flat at $1.4 million, the firm reported. Its instrument sales increased to $835,611 from $799,472. Consumables sales were down slightly from $167,380 to $146,408. Grant revenue jumped to $387,700, attributable to a Small Business Innovation Research Phase II grant from the National Institutes of Health awarded in February 2015.

The firm's net loss applicable to common shareholders widened to $7.4 million, or $.36 per share, compared to $6.3 million, or $.44 per share, in FY 2014. The loss per share was affected by a change in the number of shares outstanding, which increased following private placements in July and September.

Pressure Bio's R&D spending increased 16 percent to $1.1 million from $952,555 in 2014. The firm's SG&A spending increased 17 percent to $3.6 million from $3.1 million in 2014, driven by employee stock compensation.

The firm ended the quarter with $116,783 in cash and cash equivalents.

The Scan

J&J Booster Support

A US Food and Drug Administration advisory panel has voted to support a booster dose of Johnson & Johnson's SARS-CoV-2 vaccine, according to the Los Angeles Times.

To Keep the Cases Moving

The president of the UK Royal College of Pathologists tells the Financial Times that more investment is needed to tackle a backlog of cases.

NAS Expels Archaeologist

Science reports Luis Jaime Castillo Butters' expulsion is the first of an international member from the US National Academy of Sciences.

PLOS Papers on Angelman Syndrome-Like Cases, Salmonella Paratyphi A, SARS-CoV-2 in Brazil

In PLOS this week: exome sequencing analysis of Angelman syndrome-like cases, genetic epidemiology of Salmonella Paratyphi A, and more.